2013年

  1. Ono K: Seeing is believing - imaging of a plaque in the renal artery. J Cardiol Cases. 2014 Feb; 9(2):84-5.
  2. Kuwahara K: Role of NRSF/REST in the Regulation of Cardiac Gene Expression and Function. Circ J. 2013;77(11):2682-6.
  3. Kishimoto C, Nimata M, Okabe T, Shioji K: Immunoglobulin treatment ameliorates myocardial injury in experimental autoimmune myocarditis associated with suppression of reactive oxygen species. Int J Cardiol. 2013 Jul 15;167(1):140-5.
  4. Kishimoto C, Takamatsu N, Ochiai H, Kuribayashi K: Nucleotide differences of coxsackievirus B3 and chronic myocarditis. Heart Vessels. 2014 Feb 4 (in press).
  5. Kishimoto C, Tamaru K, Kuwahara H: Tall P waves associated with severe hypokalemia and combined electrolyte depletion. J Electrocardiol. 2014 Jan-Feb;47(1):93-4.
  6. Kishimoto C: The role of Fcγ receptors in myocardial disease. Journal of Cardiology and Therapy. (in press).
  7. Kishimoto C, Shioji K, Hashimoto T, Nonogi H, Lee JD, Kato S, Hiramatsu S, Morimoto S: Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy. Analysis of leukocyte balance. Heart Vessels. 2014 May;29(3):336-42.
  8. Saito N, Matsuo H, Kawase Y, Watanabe S, Bao B, Yamamoto E, Watanabe H, Nakatsuma K, Ueno K, Kimura T: In vitro assessment of mathematically-derived fractional flow reserve in coronary lesions with more than two sequential stenoses. J Invasive Cardiol. 2013 Dec;25(12):642-9.
  9. Ozasa N, Morimoto T, Bao B, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Tazaki J, Natsuaki M, Kimura T: ß-blocker use in patients after percutaneous coronary interventions: One size fits all? Worse outcomes in patients without myocardial infarction or heart failure. Int J Cardiol. 2013 Sep 30;168(2):774-9.
  10. Ashida N, Kishihata M, Tien DN, Kamei K, Kimura T, Yokode M: Aspirin augments the expression of adenomatous polyposis coli protein by suppression of ikkbeta. Biochem Biophys Res Commun. 2014 Apr 4;446(2):460-4.
  11. Ohno M, Hiraoka Y, Lichtenthaler SF, Nishi K, Saijo S, Matsuoka T, Tomimoto H, Araki W, Takahashi R, Kita T, Kimura T, Nishi E: Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model. Neurobiol Aging. 2014 Jan;35(1):213-22.
  12. Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Sowa N, Yahagi N, Shimano H, Matsumura S, Inoue K, Marusawa H, Nakamura T, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, Ono K: MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. Nat Commun. 2013;4:2883.
  13. Horie T, Baba O, Kuwabara Y, Yokode M, Kita T, Kimura T, Ono K: MicroRNAs and lipoprotein metabolism. J Atheroscler Thromb. 2014 Jan 23;21(1):17-22.
  14. Imai M, Kimura T, Tazaki J, Yamamoto E, Inoue K: Pathological analyses of very long-term sirolimus-eluting stent implantation in human coronary artery. J Cardiol Cases. 2013 Nov;8(5):145-47.
  15. Tazaki J, Shiomi H, Morimoto T, Imai M, Yamaji K, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T: Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple-vessel coronary artery disease: Observations from the CREDO-Kyoto PCI/CABG registry cohort-2. EuroIntervention. 2013 Aug 22;9(4):437-45.
  16. Habara S, Iwabuchi M, Inoue N, Nakamura S, Asano R, Nanto S, Hayashi Y, Shiode N, Saito S, Ikari Y, Kimura T, Hosokawa J, Nakamura M, Kotani J-, Kozuma K, Mitsudo K: A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J. 2013 Sep;166(3):527-33.
  17. Bao B, Saito N, Watanabe S, Tokushige A, Yamamoto E, Kawase Y, Kimura T, Inoue K: A novel device for antegrade percutaneous balloon aortic valvuloplasty: Feasibility of the looped inoue balloon technique in swine model. Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E564-8.
  18. Hasegawa K, Ohno S, Ashihara T, Itoh H, Ding WG, Toyoda F, Makiyama T, Aoki H, Nakamura Y, Delisle BP, Matsuura H, Horie M: A novel KCNQ1 missense mutation identified in a patient with juvenile-onset atrial fibrillation causes constitutively open IKs channels.
  19. Heart Rhythm. 2014 Jan;11(1):67-75.
  20. Nakajima S, Makiyama T, Hanazawa K, Kaitani K, Amano M, Hayama Y, Onishi N, Tamaki Y, Miyake M, Tamura T, Kondo H, Motooka M, Izumi C, Nakagawa Y, Horie M: A novel SCN5A mutation demonstrating a variety of clinical phenotypes in familial sick sinus syndrome. Intern Med. 2013;52(16):1805-8
  21. Nishikimi T, Kuwahara K, Nakagawa Y, Kangawa K, Nakao K: Adrenomedullin in Cardiovascular Disease: A Useful Biomarker, Its Pathological Roles and Therapeutic Application. Curr Protein Pept Sci. 2013 Jun;14(4):256-67.
  22. Ohno S, Nagaoka I, Fukuyama M, Kimura H, Itoh H, Makiyama T, Shimizu A, Horie M: Age-dependent clinical and genetic characteristics in Japanese patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ J. 2013;77(6):1534-42.
  23. Kozuma K, Kimura T, Kadota K, Suwa S, Kimura K, Iwabuchi M, Kawai K, Miyazawa A, Kawamura M, Nakao K, Asano R, Yamamoto T, Suzuki N, Aoki J, Kyono H, Nakazawa G, Tanabe K, Morino Y, Igarashi K: Angiographic findings of everolimus-eluting as compared to sirolimus-eluting stents: Angiographic sub-study from the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET). Cardiovasc Interv Ther. 2013 Oct;28(4):344-51.
  24. Yasuno S, Kuwahara K, Kinoshita H, Yamada C, Nakagawa Y, Usami S, Kuwabara Y, Ueshima K, Harada M, Nishikimi T, Nakao K: Angiotensin II Type 1a receptor signaling directly contributes to the increased arrhythmogenicity in cardiac hypertrophy. Br J Pharmacol. 2013 Dec;170(7):1384-95.
  25. Matsumoto E, Sasaki S, Kinoshita H, Kito T, Ohta H, Konishi M, Kuwahara K, Nakao K, Itoh N: Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16. Genes Cells. 2013 Jul;18(7):544-53.
  26. Ogita M, Miyauchi K, Morimoto T, Daida H, Kimura T, Hiro T, Nakagawa Y, Yamagishi M, Ozaki Y, Matsuzaki M: Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome - Subanalysis of the JAPAN-ACS study. Atherosclerosis. 2013 Jan;226(1):275-80.
  27. Natsuaki M, Kozuma K, Morimoto T, Kadota K, Muramatsu T, Nakagawa Y, Akasaka T, Igarashi K, Tanabe K, Morino Y, Ishikawa T, Nishikawa H, Awata M, Abe M, Okada H, Takatsu Y, Ogata N, Kimura K, Urasawa K, Tarutani Y, Shiode N, Kimura T: Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: A randomized, controlled, noninferiority trial. J Am Coll Cardiol. 2013 Jul 16;62(3):181-90.
  28. Tomita M, Asada M, Asada N, Nakamura J, Oguchi A, Higashi AY, Endo S, Robertson E, Kimura T, Kita T, Economides AN, Kreidberg J, Yanagita M: Bmp7 Maintains Undifferentiated Kidney Progenitor Population and Determines Nephron Numbers at Birth. PLoS One. 2013 Aug 26;8(8):e73554.
  29. Kato K, Makiyama T, Wu J, Ding WG, Kimura H, Naiki N, Ohno S, Itoh H, Nakanishi T, Matsuura H, Horie M: Cardiac Channelopathies Associated with Infantile Fatal Ventricular Arrhythmias: From the Cradle to the Bench. J Cardiovasc Electrophysiol. 2014 Jan;25(1):66-73.
  30. Funayama A, Shishido T, Netsu S, Narumi T, Kadowaki S, Takahashi H, Miyamoto T, Watanabe T, Woo CH, Abe JI, Kuwahara K, Nakao K, Takeishi Y, Kubota I: Cardiac nuclear High Mobility Group Box 1 prevents the development of cardiac hypertrophy and heart failure. Cardiovasc Res. 2013 Sep 1;99(4):657-64.
  31. Toyofuku M, Kimura T, Morimoto T, Hayashi Y, Shiode N, Nishikawa H, Nakao K, Shirota K, Kawai K, Hiasa Y, Kadota K, Nozaki Y, Isshiki T, Sone T, Mitsudo K: Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: Insights from the j-Cypher registry. JACC Cardiovasc Interv. 2013 Jul;6(7):654-63.
  32. Nishida K, Kimura T, Kawai K, Miyano I, Nakaoka Y, Yamamoto S, Kaname N, Seki S, Kubokawa S, Fukatani M, Hamashige N, Morimoto T, Mitsudo K: Comparison of outcomes using the sirolimus-eluting stent in calcified versus non-calcified native coronary lesions in patients on-versus not on-chronic hemodialysis (from the j-Cypher Registry). Am J Cardiol. 2013 Sep 1;112(5):647-55.
  33. Morikami Y, Natsuaki M, Morimoto T, Ono K, Nakagawa Y, Furukawa Y, Sakata R, Aota M, Okada Y, Onoe M, Kawasuji M, Koshiji T, Nakajima H, Nishizawa J, Yamanaka K, Yamamoto H, Kimura T: CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: An observation from the CREDO-Kyoto Registry Cohort-2. Atherosclerosis. 2013 Jun;228(2):426-31.
  34. Yamamoto E, Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Ono K, Mitsudo K, Nobuyoshi M, Doi O, Tamura T, Tanaka M, Kimura T: CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Long-Term Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusion (from the CREDO-Kyoto Registry Cohort-2). Am J Cardiol. 2013 Sep 15;112(6):767-74.
  35. Hiraoka Y, Matsuoka T, Ohno M, Nakamura K, Saijo S, Matsumura S, Nishi K, Sakamoto J, Chen P-, Inoue K, Fushiki T, Kita T, Kimura T, Nishi E: Critical roles of nardilysin in the maintenance of body temperature homoeostasis. Nat Commun. 2014;5:3224.
  36. Nakamura M, Yamagishi M, Ueno T, Hara K, Ishiwata S, Itoh T, Hamanaka I, Wakatsuki T, Sugano T, Kawai K, Kimura T: Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry. Cardiovasc Interv Ther. 2013 Apr;28(2):162-9.
  37. Nakamura M, Yamagishi M, Ueno T, Hara K, Ishiwata S, Itoh T, Hamanaka I, Wakatsuki T, Sugano T, Kawai K, Kimura T: Current treatment of ST elevation acute myocardial infarction in Japan: Door-to-balloon time and total ischemic time from the J-AMI registry. Cardiovasc Interv Ther. 2013 Jan;28(1):30-6.
  38. Nishikimi T, Okamoto H, Nakamura M, Ogawa N, Horii K, Nagata K, Nakagawa Y, Kinoshita H, Yamada C, Nakao K, Minami T, Kuwabara Y, Kuwahara K, Masuda I, Kangawa K, Minamino N, Nakao K: Direct Immunochemiluminescent Assay for proBNP and Total BNP in Human Plasma proBNP and Total BNP Levels in Normal and Heart Failure. PLoS One. 2013;8(1):e53233.
  39. Nishino T, Furukawa Y, Kaji S, Ehara N, Shiomi H, Kim K, Kitai T, Kinoshita M, Morimoto T, Sakata R, Kimura T: Distinct survival benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers in revascularized coronary artery disease patients according to history of myocardial infarction. Circ J. 2013;77(5):1242-52.
  40. Saito R, Shirakawa R, Nishiyama H, Kobayashi T, Kawato M, Kanno T, Nishizawa K, Matsui Y, Ohbayashi T, Horiguchi M, Nakamura T, Ikeda T, Yamane K, Nakayama E, Nakamura E, Toda Y, Kimura T, Kita T, Ogawa O, Horiuchi H: Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer. Oncogene. 2013 Feb 14;32(7):894-902.
  41. Imai S, Fukui M, Ozasa N, Ozeki T, Kurokawa M, Komatsu T, Kajiyama S: Eating vegetables before carbohydrates improves postprandial glucose excursions. Diabet Med. 2013 Mar;30(3):370-2.
  42. Hirano E, Shimada K, Komiyama T, Fujita M, Kishimoto C: Erythromycin treatment suppresses myocardial injury in autoimmune myocarditis in rats via suppression of superoxide production. Int J Cardiol. 2013 Sep 1;167(5):2228-33.
  43. Bourantas CV, Papafaklis MI, Lakkas L, Sakellarios A, Onuma Y, Zhang Y-, Muramatsu T, Diletti R, Bizopoulos P, Kalatzis F, Naka KK, Fotiadis DI, Wang J, Garcia Garcia HM, Kimura T, Michalis LK, Serruys PW: Fusion of optical coherence tomographic and angiographic data for more accurate evaluation of the endothelial shear stress patterns and neointimal distribution after bioresorbable scaffold implantation: comparison with intravascular ultrasound-derived reconstructions. Int J Cardiovasc Imaging. 2014 Mar;30(3):485-94.
  44. Kawamura M, Ohno S, Naiki N, Nagaoka I, Dochi K, Wang Q, Hasegawa K, Kimura H, Miyamoto A, Mizusawa Y, Itoh H, Makiyama T, Sumitomo N, Ushinohama H, Oyama K, Murakoshi N, Aonuma K, Horigome H, Honda T, Yoshinaga M, Ito M, Horie M: Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan. Circ J. 2013;77(7):1705-13.
  45. Uosaki H, Magadum A, Seo K, Fukushima H, Takeuchi A, Nakagawa Y, Moyes KW, Narazaki G, Kuwahara K, Laflamme M, Matsuoka S, Nakatsuji N, Nakao K, Kwon C, Kass DA, Engel FB, Yamashita JK: Identification of Chemicals Inducing Cardiomyocyte Proliferation in Developmental Stage-Specific Manner with Pluripotent Stem Cells. Circ Cardiovasc Genet. 2013 Dec;6(6):624-33.
  46. Marui A, Okabayashi H, Komiya T, Tanaka S, Furukawa Y, Kita T, Kimura T, Sakata R: Impact of occult renal impairment on early and late outcomes following coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2013 Oct;17(4):638-43.
  47. Morikami Y, Natsuaki M, Morimoto T, Ono K, Nakagawa Y, Furukawa Y, Sakata R, Aota M, Okada Y, Onoe M, Kawasuji M, Koshiji T, Nakajima H, Nishizawa J, Yamanaka K, Yamamoto H, Kimura T: Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: An observation from the CREDO-Kyoto Registry Cohort-2. Atherosclerosis. 2013 Jun;228(2):426-31.
  48. Kuwabara Y, Kuwahara K, Takano M, Kinoshita H, Arai Y, Yasuno S, Nakagawa Y, Igata S, Usami S, Minami T, Yamada Y, Nakao K, Yamada C, Shibata J, Nishikimi T, Ueshima K, Nakao K: Increased Expression of HCN Channels in the Ventricular Myocardium Contributes to Enhanced Arrhythmicity in Mouse Failing Hearts. J Am Heart Assoc. 2013 May 24;2(3):e000150.
  49. Tokushige A, Shiomi H, Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Hamasaki S, Tei C, Nakashima H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T: Influence of initial acute myocardial infarction presentation on the outcome of surgical procedures after coronary stent implantation: a report from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Cardiovasc Interv Ther. 2013 Jan;28(1):45-55.
  50. Fukuyama M, Ohno S, Wang Q, Kimura H, Makiyama T, Itoh H, Ito M, Horie M: L-type calcium channel mutations in Japanese patients with inherited arrhythmias. Circ J. 2013;77(7):1799-806.
  51. Takanabe-Mori R, Ono K, Wada H, Takaya T, Ura S, Yamakage H, Satoh-Asahara N, Shimatsu A, Takahashi Y, Fujita M, Fujita Y, Sawamura T, Hasegawa K: Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Plays an Important Role in Vascular Inflammation in Current Smokers. J Atheroscler Thromb. 2013;20(6):585-90.
  52. Villafañe J, Atallah J, Gollob MH, Maury P, Wolpert C, Gebauer R, Watanabe H, Horie M, Anttonen O, Kannankeril P, Faulknier B, Bleiz J, Makiyama T, Shimizu W, Hamilton RM, Young ML: Long-term follow-up of a pediatric cohort with short QT syndrome. J Am Coll Cardiol. 2013 Mar 19;61(11):1183-91.
  53. Yamamoto E, Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Ono K, Mitsudo K, Nobuyoshi M, Doi O, Tamura T, Tanaka M, Kimura T: Long-term outcomes after percutaneous coronary intervention for chronic total occlusion (from the CREDO-Kyoto registry cohort-2). Am J Cardiol. 2013 Sep 15;112(6):767-74.
  54. Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, Kimura T, Matsubara T, Ikari Y, Kimura K, Tsukahara K, Origasa H, Morino Y, Tsutsui H, Kobayashi M, Isshiki T: Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: Prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J. 2013;77(4):934-43.
  55. Tamaki Y, Iwanaga Y, Niizuma S, Kawashima T, Kato T, Inuzuka Y, Horie T, Morooka H, Takase T, Akahashi Y, Kobuke K, Ono K, Shioi T, Sheikh SP, Ambartsumian N, Lukanidin E, Koshimizu TA, Miyazaki S, Kimura T: Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts. J Mol Cell Cardiol. 2013 Apr;57:72-81.
  56. Watanabe S, Saito N, Bao B, Tokushige A, Watanabe H, Yamamoto E, Kawase Y, Kimura T: Microcatheter-facilitated reverse wire technique for side branch wiring in bifurcated vessels: An in vitro evaluation. EuroIntervention. 2013 Nov 22;9(7):870-7.
  57. Nagao K, Sowa N, Inoue K, Tokunaga M, Fukuchi K, Uchiyama K, Ito H, Hayashi F, Makita T, Inada T, Tanaka M, Kimura T, and Ono K: Myocardial expression level of neural cell adhesion molecule correlates with reduced left ventricular function in human cardiomyopathy. Circ Heart Fail. 2014 Mar 1;7(2):351-8.
  58. Shimada K, Uzui H, Ueda T, Lee JD, Kishimoto C: N-Acetylcysteine Ameliorates Experimental Autoimmune Myocarditis in Rats via Nitric Oxide. J Cardiovasc Pharmacol Ther (in press).
  59. Ishikawa T, Takahashi N, Ohno S, Sakurada H, Nakamura K, On YK, Park JE, Makiyama T, Horie M, Arimura T, Makita N, Kimura A: Novel SCN3B mutation associated with brugada syndrome affects intracellular trafficking and function of Nav1.5. Circ J. 2013;77(4):959-67.
  60. Hamatani Y, Saito N, Tazaki J, Natsuaki M, Nakai K, Makiyama T, Sasaki Y, Imai M, Watanabe S, Shioi T, Kimura T, Inoue K: Percutaneous balloon valvuloplasty for bioprosthetic mitral valve stenosis. Heart Vessels. 2013 Sep;28(5):667-71.
  61. Yamaji K, Kimura T, Morimoto T, Nakagawa Y, Inoue K, Nobuyoshi M, Mitsudo K: Percutaneous coronary intervention in patients with previous coronary artery bypass grafting (from the j-Cypher Registry). Am J Cardiol. 2013 Oct 15;112(8):1110-9.
  62. Kozuma K, Kimura T, Suzuki N, Miyazawa A, Waseda K, Honda Y, Morimoto T, Aizawa T, Mitsudo K, Miyazaki S, Yamaguchi T, Isshiki T: Peri-stent contrast staining and very late stent thrombosis after sirolimus-eluting stent implantation: An observation from the RESTART (REgistry of Stent Thrombosis for review and Re-evaluaTion) angiographic substudy. EuroIntervention. 2013 Nov 22;9(7):831-40.
  63. Okuda J, Niizuma S, Shioi T, Kato T, Inuzuka Y, Kawashima T, Tamaki Y, Kawamoto A, Tanada Y, Iwanaga Y, Narazaki M, Matsuda T, Adachi S, Soga T, Takemura G, Kondoh H, Kita T, Kimura T: Persistent Overexpression of Phosphoglycerate Mutase, a Glycolytic Enzyme, Modifies Energy Metabolism and Reduces Stress Resistance of Heart in Mice. PLoS One. 2013 Aug 12;8(8):e72173.
  64. Kitai Y, Ozasa N, Morimoto T, Bao B, Furukawa Y, Nakagawa Y, Kadota K, Yanagita M, Shizuta S, Kimura T: Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention. Int J Cardiol. 2013 Oct 15;168(6):5221-8.
  65. Fukushima Y, Daida H, Morimoto T, Kasai T, Miyauchi K, Yamagishi S-, Takeuchi M, Hiro T, Kimura T, Nakagawa Y, Yamagishi M, Ozaki Y, Matsuzaki M: Relationship between Advanced Glycation End Products and Plaque Progression in Patients with Acute Coronary Syndrome: The JAPAN-ACS Sub-study. Cardiovasc Diabetol. 2013 Jan 7;12:5.
  66. Stefanini GG, Baber U, Windecker S, Morice M-, Sartori S, Leon MB, Stone GW, Serruys PW, Wijns W, Weisz G, Camenzind E, Steg PG, Smits PC, Kandzari D, Von Birgelen C, Galatius S, Jeger RV, Kimura T, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim H-, Valgimigli M, Kastrati A, Chieffo A, Mehran R: Safety and effi cacy of drug-eluting stents in women: A patient-level pooled analysis of randomised trials. Lancet. 2013 Dec 7;382(9908):1879-88.
  67. Toyota T, Furukawa Y, Ehara N, Funakoshi S, Morimoto T, Kaji S, Nakagawa Y, Kadota K, Iwabuchi M, Shiomi H, Yamamuro A, Kinoshita M, Kitai T, Kim K, Tani T, Kobori A, Kita T, Sakata R, Kimura T: Sex-based differences in clinical practice and outcomes for Japanese patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J. 2013;77(6):1508-17.
  68. Tamaki Y, Iwanaga Y, Niizuma S, Kawashima T, Kato T, Inuzuka Y, Horie T, Morooka H, Takase T, Akahashi Y, Kobuke K, Ono K, Shioi T, Sheikh SP, Ambartsumian N, Lukanidin E, Koshimizu TA, Miyazaki S, Kimura T: Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts. J Mol Cell Cardiol. 2013 Apr;57:72-81.
  69. Kamakura T, Kawata H, Nakajima I, Yamada Y, Miyamoto K, Okamura H, Noda T, Satomi K, Aiba T, Takaki H, Aihara N, Kamakura S, Kimura T, Shimizu W: Significance of non-type 1 anterior early repolarization in patients with inferolateral early repolarization syndrome. J Am Coll Cardiol. 2013 Oct 22;62(17):1610-8.
  70. Ruwald MH, Okumura K, Kimura T, Aonuma K, Shoda M, Kutyifa V, Ruwald A-H, McNitt S, Zareba W, Moss AJ: Syncope in High-Risk Cardiomyopathy Patients with Implantable Defibrillators: Frequency, Risk Factors, Mechanisms, and Association with Mortality: Results from the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Study. Circulation. 2014 Feb 4;129(5):545-52.
  71. Nakagawa Y, Nishikimi T, Kuwahara K, Yasuno S, Kinoshita H, Kuwabara Y, Nakao K, Minami T, Yamada C, Ueshima K, Ikeda Y, Okamoto H, Horii K, Nagata K, Kangawa K, Minamino N, Nakao K: The Effects of Super-Flux (High Performance) Dialyzer on Plasma Glycosylated Pro-B-Type Natriuretic Peptide (proBNP) and Glycosylated N-Terminal proBNP in End-Stage Renal Disease Patients on Dialysis. PLoS One. 2014 Mar 25;9(3):e92314.
  72. Kamakura T, Makiyama T, Sasaki K, Yoshida Y, Wuriyanghai Y, Chen J, Hattori T, Ohno S, Kita T, Horie M, Yamanaka S, Kimura T: Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ J. 2013;77(5):1307-14.
  73. Kawase Y, Saito N, Watanabe S, Bao B, Yamamoto E, Watanabe H, Higami H, Matsuo H, Ueno K, Kimura T: Utility of a scoring balloon for a severely calcified lesion: bench test and finite element analysis. Cardiovasc Interv Ther. 2014 Apr;29(2):134-9.
  74. Oi M, Toyofuku M, Matsumura Y, Motohashi Y, Takahashi K, Kawase Y, Ko E, Tanaka M, Kitada M, Yuzuki Y, Tamura T, Tanaka N, Kimura T: Utility of nicorandil for the measurement of coronary fractional flow reserve. Cardiovasc Interv Ther. 2014 Jan;29(1):24-30.
  75. Nishida M, Ishikawa T, Saiki S, Sunggip C, Aritomi S, Harada E, Kuwahara K, Hirano K, Mori Y, Kim-Mitsuyama S: Voltage-dependent N-type Ca2+ channels in endothelial cells contribute to oxidative stress-related endothelial dysfunction induced by angiotensin II in mice. Biochem Biophys Res Commun. 2013 May 3;434(2):210-6.
  76. Bao B, Ozasa N, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Natsuaki M, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T: ß-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction. Cardiovasc Interv Ther. 2013 Apr;28(2):139-47.
  77. Kishimoto C: Therapy with immunoglobulin in patients with acute myocarditis. In Intravenous immunoglobin (IVIG): Clinical uses in autoimmune disoders potential complications and long-term efficacy. ed. by Columbus N, NOVA, New York. (単行本)

ページの先頭へ